30-7514US DGP-G (FDA cleared)

Intended Use:

AESKULISA DGP IgG is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgG antibodies against deamidated Gliadin-specific peptides (DGP) in human serum.

Recombinant Antigens:

Deamidated gliadin-peptides

Native Antigens:

n.a.

Kit Configuration

Type: AESKULISA®
Method: Elisa
Reference: 30-7514US
Description: DGP-G (FDA cleared)
Kit Configuration: Single - G
Cut Off: 15
Range: 0 - 300 U/ml
Standard: -
Antibodies: IgG

More in this category: « 30-7503US tTg-A (FDA cleared)